Page last updated: 2024-09-02

ci 988 and apomorphine

ci 988 has been researched along with apomorphine in 1 studies

Compound Research Comparison

Studies
(ci 988)
Trials
(ci 988)
Recent Studies (post-2010)
(ci 988)
Studies
(apomorphine)
Trials
(apomorphine)
Recent Studies (post-2010) (apomorphine)
1478149,205287780

Protein Interaction Comparison

ProteinTaxonomyci 988 (IC50)apomorphine (IC50)
Tryptophan 5-hydroxylase 1Rattus norvegicus (Norway rat)0.22
D(2) dopamine receptorHomo sapiens (human)0.0146
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.75
DRattus norvegicus (Norway rat)0.4744
D(3) dopamine receptorRattus norvegicus (Norway rat)0.1432
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.063
D(2) dopamine receptorBos taurus (cattle)0.3385
D(1A) dopamine receptorHomo sapiens (human)0.025
D(4) dopamine receptorHomo sapiens (human)0.025
D(1B) dopamine receptorHomo sapiens (human)0.025
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)7.75
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(4) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(3) dopamine receptorHomo sapiens (human)0.025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.75
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0813
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.205
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)1.35
DBos taurus (cattle)0.3385

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoffersen, CL; Meltzer, LT; Razmpour, A; Serpa, KA1

Other Studies

1 other study(ies) available for ci 988 and apomorphine

ArticleYear
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Synapse (New York, N.Y.), 1993, Volume: 13, Issue:2

    Topics: Animals; Apomorphine; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Indoles; Male; Meglumine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substantia Nigra; Tegmentum Mesencephali

1993